Asia Pacific Intracranial Aneurysm Market Report and Forecast 2024-2032

The global intracranial aneurysm market size was valued at USD 1.2 billion in 2023, with Asia Pacific holding a significant market share. The market is driven by technological advances in surgical approaches and increased healthcare access. It is expected to grow at a CAGR of 9.3% during the forecast period of 2024-2032, with the values likely to attain USD 2.6 billion by 2032.

Key Takeaways

• Recent data reveals that intracranial aneurysm is a common cerebrovascular disease, with a prevalence of 3.2% and 7% estimated in the global population and China, respectively. The rising cases of intracranial aneurysms directly impact the market demand.
• One of the major Asia Pacific intracranial aneurysm market trends is the rise in clinical studies to enhance medical device design and usage for treating intracranial aneurysms. For instance, INSPIRE-A is an international registry sponsored by Medtronic plc that enables standardized assessment of flow-diverter imaging results in endovascular aneurysm care.
• The market share is positively influenced by the advancement in diagnostic techniques. In April 2024, a study published in the Lancet revealed that a team of Chinese researchers developed a CT angiography (CTA)-based AI model for intracranial aneurysm detection, showing robust clinical potential in detecting the aneurysm.

Asia Pacific Intracranial Aneurysm Market Analysis

An intracranial aneurysm, also known as cerebral or brain aneurysm, is characterized by the presence of a bulge or ballooning in a blood vessel in the brain. Often developed at points in arteries where the vessel wall is weakened, the rupturing of an aneurysm can result in bleeding into the brain or the surrounding areas. This can cause stroke, brain damage, or even death if immediate treatment is not provided to the patient. There is a growing demand for minimally invasive surgical techniques such as endovascular coiling and flow diversion, which greatly reduce the risk of complications and improve patient outcomes. The rising availability of such treatments due to increased public and private sector investments is expected to drive the Asia Pacific intracranial aneurysm market growth.

In Asia Pacific, the rising cases of intracranial aneurysms can be attributed to the growing aging populations, increased smoking, and other lifestyle-related health issues. Recent data reveals that intracranial aneurysm is a common cerebrovascular disease, with a prevalence of 3.2% and 7% estimated in the global population and China, respectively. Subarachnoid hemorrhage, which is primarily caused by aneurysmal rupture, has a case fatality of 50%, which indicates the critical need for effective treatment interventions. Thus, with the growing prevalence rate of the condition, the Asia Pacific intracranial aneurysm market demand is likely to witness a surge.

One of the major market trends is the rise in clinical studies to enhance the design and usage of medical devices for treating intracranial aneurysms and improve patient outcomes. For instance, INSPIRE-A is an international registry sponsored by Medtronic plc that enables standardized assessment of flow-diverter imaging results in endovascular aneurysm care. The registry, with over 1,400 participants enrolled from more than 40 sites such as in China and Australia, monitors and evaluates outcomes in intracranial aneurysm patients, treated with Medtronic neurovascular medical devices. The findings from such global registries are expected to offer insights into the performance of flow diverters, influencing clinical guidelines and elevating the Asia Pacific intracranial aneurysm market value significantly in the forecast period.

The market is also influenced by the advancement in diagnostic techniques facilitating the early detection and accurate diagnosis of intracranial aneurysms. A study published in the Lancet in April 2024 revealed that a team of Chinese researchers developed a CT angiography (CTA)-based AI model for intracranial aneurysm detection. The early-stage clinical validation study reported that the deep-learning model exhibited robust clinical potential in detecting the aneurysm as well as improved diagnostic performance and practical implementation in real-world settings. The adoption of such innovative diagnostic technologies is anticipated to accelerate market growth in the coming years.

Asia Pacific Intracranial Aneurysm Market Segmentation

Market Breakup by Treatment Type

• Endovascular Coiling
• Surgical Clipping
• Flow Diverters
• Other Treatment Types

Market Breakup by End User

• Hospitals
• Clinics
• Others

Market Breakup by Countries

• China
• Japan
• India
• ASEAN
• Australia
• Others

Asia Pacific Intracranial Aneurysm Market: Competitor Landscape

The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Medtronic
• Stryker
• MicroPort Scientific Corporation
• Johnson & Johnson Services, Inc.
• MicroVention Inc.
• Integra LifeSciences
• B. Braun Melsungen AG
• RAUMEDIC AG
• Mizuho Medical Co. Ltd.
• Penumbra, Inc.

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

FAQs

What is the Asia Pacific intracranial aneurysm market forecast outlook for 2024-2032?
The Asia Pacific intracranial aneurysm market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 8.8% during the forecast period of 2024-2032 and is likely to reach a market value of USD 2.6 billion by 2032.

What are the major factors aiding the Asia Pacific intracranial aneurysm market demand?
The rising demand for minimally invasive surgical techniques such as endovascular coiling and flow diversion is fuelling the demand for the market.

What are the major Asia Pacific intracranial aneurysm market trends?
One of the significant trends in the market is the rise in clinical studies to enhance medical device design and usage for treating intracranial aneurysms. For instance, INSPIRE-A is an international registry sponsored by Medtronic plc that enables standardized assessment of flow-diverter imaging results in endovascular aneurysm care.

What is the market segmentation based on the treatment type?
Based on the treatment type, the market is segmented into endovascular coiling, surgical clipping, and flow diverters, among other treatment types.

What are the major end users of the market?
End users of the market are hospitals and clinics, among other end-users.

What is the market segmentation by countries?
The market segmentation by countries includes China, Japan, India, ASEAN, and Australia, among others.

Who are the key players involved in the Asia Pacific intracranial aneurysm market?
The key players in the market are Medtronic, Stryker, MicroPort Scientific Corporation, Johnson & Johnson Services, Inc., MicroVention Inc., Integra LifeSciences, B. Braun Melsungen AG, RAUMEDIC AG, Mizuho Medical Co. Ltd., and Penumbra, Inc.


This product will be delivered within 5-7 business days.